Symyx Launches Research Services for Life Sciences
News Jul 25, 2008
Symyx Technologies, Inc. has announced the launch of its new client-directed and collaborative research services for Life Sciences.
These services allow clients to access Symyx’s installed base of parallel experimentation and testing capabilities through packaged offerings for solubility studies, polymorph screening, salt selection, co-crystallization, API stability in liquid and solid formulations, excipient compatibility, organic synthesis and process optimization.
Symyx recently signed a one-year agreement with Bristol-Myers Squibb Company for the use of Symyx Research Services for solubility studies. Under terms of the agreement, Symyx will perform solubility studies for Bristol-Myers Squibb through May, 2009.
“Symyx Research is continuing to transform its offerings into packaged, smaller scope and easily accessible solutions. Symyx Research Services combines our industry-leading research capabilities with real-time data analysis to deliver results on demand, freeing companies from internal capability constraints while substantially reducing the cost of R&D,” said Richard Boehner, President of Symyx Research.
“We are pleased to enter this agreement with Bristol-Myers Squibb to provide solubility research services which will help them achieve a greater level of R&D efficiency.”
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018